Our results explained, at lease in part, the reduced responsiveness of osteoporotic MSCs to BMP2, and suggested a new therapeutic strategy to improve the clinical efficacy of BMP2 for the treatment of osteoporosis. Here, BMP2 is linked to osteoporosis.